Outsourcing: OK for Big Pharma, but not for consumers?

From the Pakistan Daily Times:

US firms likely to outsource pharma products’ production

ISLAMABAD: A number of US pharmaceutical companies are planning to outsource research and development projects and production of pharmaceuticals to countries which offer suitable conditions for these activities, Alan P. Larson, Senior International Investment Adviser to a US-based law firm and former under secretary of Economic Business & Agricultural Affairs, said during a meeting with Prime Minister Shaukat Aziz here on Wednesday…

(Aziz) said wide-ranging structural reforms introduced during the last seven years, coupled with macro-economic stability, consistency and continuity of policies, have transformed Pakistan into a destination of choice for foreign investors and during the last financial year the country received a total investment of $3.8 billion which was a record in the country’s history … Mr Larson said there is tremendous potential in Pakistan to undertake research in life sciences, which will lead to increase in production and export of pharmaceuticals from Pakistan.

Let me get this straight: Big Pharma can get its R&D done in Pakistan, but U.S. consumers can’t buy their drugs in Canada because of Big Pharma’s high R&D costs?

Right.

About Cary Byrd

eDrugSearch founder, Cary Byrd, has been called an “e-health innovator” by MarketIntellNow, interviewed by top pharmaceutical industry journalists, invited to Matthew Holt’s Health 2.0 Conference and a Consumer Report's health summit, and highlighted on numerous health blogs.

eDrugSearch.com - Search. Compare. Save.

Leave a Reply

Join Our Free Newsletter

Please enter email id

Get a weekly dose of money-saving tips on your medications, drug side effects alerts, drug interaction warnings, free prescription coupons, late-breaking safety information and much, much more!

Share via
Copy link